How has Aclaris Therapeutics's change in accrued liabilities changed year-over-year?

Aclaris Therapeutics's change in accrued liabilities increased by 72.6% year-over-year, from -$11.04M to -$3.03M.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

Aclaris Therapeutics ACRS Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

IncyteINCY

-$84.73M-213%

Corvus PharmaceuticalsCRVS

$499K+242%

Upstream Bio, Inc.UPB

$1.23M+166%

Avalo TherapeuticsAVTX

-$1.5M+12.1%

Shattuck Labs, Inc.STTK

-$1.96M-173%

Apogee Therapeutics, Inc.APGE

$4.67M+77.0%

Other financials

Income statement

See full

Revenue$2.0M+37.2%

Gross profit$1.6M+68.7%

Operating income-$22.2M-22.7%

Net income-$19.8M-31.4%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$28.7M-5.6%

Total debt$2.0M-20.1%

Total equity$143.6M-0.3%

Total assets$198.7M+0.3%

Cash flow

See full

Operating cash flow-$18.1M-39.0%

CapEx$13.0K-69.8%

Free cash flow-$18.2M-38.6%

Valuation

See full

Market cap$685.75M+337%

Enterprise value$659.07M+410%

P/S82×+73.1×

Profitability

See full

Gross margin76.3%-9.7pp

Operating margin-961.9%+259pp

Net margin-832.6%+132pp

FCF margin-624.9%—

Returns & leverage

See full

Return on equity-48.4%-15.4pp

Debt / equity0×0.0×

Current ratio4×-1.0×

Where this comes from

Reported directly by Aclaris Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aclaris Therapeutics's change in accrued liabilities?: Aclaris Therapeutics (ACRS) reported change in accrued liabilities of -$3.03M in Q1 2026.
How has Aclaris Therapeutics's change in accrued liabilities changed year-over-year?: Aclaris Therapeutics's change in accrued liabilities increased by 72.6% year-over-year, from -$11.04M to -$3.03M.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.